What is Alexandra Kazakis's NPI number?

Alexandra Kazakis's National Provider Identifier (NPI) is 1386736288, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Alexandra Kazakis's specialty?

Alexandra Kazakis is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Alexandra Kazakis located?

Alexandra Kazakis's practice location on file with NPPES is 3022 Williams Dr, Fairfax, VA 22031-4600.

What is Alexandra Kazakis's phone number?

The practice phone number listed in the NPPES registry for Alexandra Kazakis is (703) 573-5252.

Does Alexandra Kazakis accept Medicare?

Alexandra Kazakis is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Alexandra Kazakis's NPI active?

Yes — Alexandra Kazakis's NPI (1386736288) is active in the NPPES registry as of the last update on 2008-06-02.

IndividualActiveAccepts Medicare

Alexandra Kazakis, MD

NPI 1386736288 · Dermatology Physician · Fairfax, VA

Alexandra Kazakis, MD is a Dermatology Physician provider in Fairfax, VA (NPI 1386736288).

Provider details

NPI number: 1386736288
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: MD
Sex: Female
Sole proprietor: Yes
License: 0101040814 (VA)

Practice location

3022 Williams Dr

Suite 101

Fairfax, VA 22031-4600

Phone: (703) 573-5252

Fax: (703) 573-5254

Approximate (ZIP-level) locationGet directions

More VA providers

Mailing address

3022 Williams Dr

Fairfax, VA 22031-4600

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 0101040814 (VA)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(91/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
20 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
6,616 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	3,727	$8
Destruction of Precancer Skin Growth, 1 Growth17000	1,098	$67
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,096	$100
Destruction of Skin Growth, 1-14 Growths17110	289	$130
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212	200	$63
Biopsy of Related Skin Growth, First Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 21 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	108	53
Metronidazole	65	43
Ammonium Lactate	62	25
Ciclopirox Olaminebrand: Ciclopirox	28	20
Valacyclovir Hclbrand: Valacyclovir	27	14
Mometasone Furoate	24	16
Ciclopirox	22	16
Alclometasone Dipropionate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$474 across 5 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-09-28
Last updated: 2008-06-02

Frequently asked questions

What is Alexandra Kazakis's NPI number?: Alexandra Kazakis's National Provider Identifier (NPI) is 1386736288, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Alexandra Kazakis's specialty?: Alexandra Kazakis is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Alexandra Kazakis located?: Alexandra Kazakis's practice location on file with NPPES is 3022 Williams Dr, Fairfax, VA 22031-4600.
What is Alexandra Kazakis's phone number?: The practice phone number listed in the NPPES registry for Alexandra Kazakis is (703) 573-5252.
Does Alexandra Kazakis accept Medicare?: Alexandra Kazakis is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Alexandra Kazakis's NPI active?: Yes — Alexandra Kazakis's NPI (1386736288) is active in the NPPES registry as of the last update on 2008-06-02.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	3,727	$8
Destruction of Precancer Skin Growth, 1 Growth17000	1,098	$67
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,096	$100
Destruction of Skin Growth, 1-14 Growths17110	289	$130
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212	200	$63
Biopsy of Related Skin Growth, First Growth

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 21 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	108	53
Metronidazole	65	43
Ammonium Lactate	62	25
Ciclopirox Olaminebrand: Ciclopirox	28	20
Valacyclovir Hclbrand: Valacyclovir	27	14
Mometasone Furoate	24	16
Ciclopirox	22	16
Alclometasone Dipropionate

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$474 across 5 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments